These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3325929)

  • 1. Ciprofloxacin for infection prevention in patients with acute leukemia.
    Rozenberg-Arska M; Dekker AW
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S45-7. PubMed ID: 3325929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.
    Dekker AW; Rozenberg-Arska M; Verhoef J
    Ann Intern Med; 1987 Jan; 106(1):7-11. PubMed ID: 3466563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria.
    Rozenberg-Arska M; Dekker AW; Verhoef J
    Infection; 1983; 11(3):167-9. PubMed ID: 6604030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukaemia.
    Starke ID; Donnelly P; Catovsky D; Darrell J; Johnson SA; Goldman JM; Galton DA
    Lancet; 1982 Jan; 1(8262):5-6. PubMed ID: 6119443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora.
    Rozenberg-Arska M; Dekker AW; Verhoef J
    J Infect Dis; 1985 Jul; 152(1):104-7. PubMed ID: 3159811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients.
    Henry SA
    Am J Med; 1984 Apr; 76(4):645-51. PubMed ID: 6369979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia.
    Wade JC; Schimpff SC; Hargadon MT; Fortner CL; Young VM; Wiernik PH
    N Engl J Med; 1981 Apr; 304(18):1057-62. PubMed ID: 6782486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of infection in the neutropenic patient.
    Verhoef J; Rozenberg-Arska M; Dekker A
    Rev Infect Dis; 1989; 11 Suppl 7():S1545-50. PubMed ID: 2513630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blind comparison of ciprofloxacin and trimethoprim-sulfamethoxazole for complicated urinary tract infections.
    Allais JM; Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1327-30. PubMed ID: 3195995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin.
    Arning M; Wolf HH; Aul C; Heyll A; Scharf RE; Scheider W
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():137-42. PubMed ID: 2286588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia.
    Dekker AW; Rozenberg-Arska M; Sixma JJ; Verhoef J
    Ann Intern Med; 1981 Nov; 95(5):555-9. PubMed ID: 6794406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia.
    Goorin AM; Hershey BJ; Levin MJ; Siber GR; Gelber RD; Flynn K; Lew M; Beckett K; Blanding P; Sallan SE
    Pediatr Infect Dis; 1985; 4(3):265-9. PubMed ID: 3889875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral trimethoprim/sulfamethoxazole in attempt to prevent infection after induction chemotherapy for acute leukemia.
    Henry SA; Armstrong D; Kempin S; Gee T; Arlin Z; Clarkson B
    Am J Med; 1984 Oct; 77(4):663-6. PubMed ID: 6435446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of infection in acute leukemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis.
    Kurrle E; Dekker AW; Gaus W; Haralambie E; Krieger D; Rozenberg-Arska M; de Vries-Hospers HG; van der Waaij D; Wendt F
    Infection; 1986; 14(5):226-32. PubMed ID: 3491791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of infection in patients with acute nonlymphocytic leukemia by several drug treatment regimens.
    Verhoef J; Rozenberg-Arska M; Dekker A
    Haematol Blood Transfus; 1987; 30():188-93. PubMed ID: 3114058
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial.
    Pizzo PA; Robichaud KJ; Edwards BK; Schumaker C; Kramer BS; Johnson A
    J Pediatr; 1983 Jan; 102(1):125-33. PubMed ID: 6336781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis.
    Fox BC; Sollinger HW; Belzer FO; Maki DG
    Am J Med; 1990 Sep; 89(3):255-74. PubMed ID: 2118307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.
    Hibberd PL; Tolkoff-Rubin NE; Doran M; Delvecchio A; Cosimi AB; Delmonico FL; Auchincloss H; Rubin RH
    Online J Curr Clin Trials; 1992 Aug; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethoprim-sulfamethoxazole for acute dysuria in women: a single-dose or 10-day course. A double-blind, randomized trial.
    Fihn SD; Johnson C; Roberts PL; Running K; Stamm WE
    Ann Intern Med; 1988 Mar; 108(3):350-7. PubMed ID: 3257670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
    Bow EJ; Rayner E; Scott BA; Louie TJ
    Antimicrob Agents Chemother; 1987 Apr; 31(4):551-7. PubMed ID: 3300532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.